Citation: F. Yeung et al., Regions of prostate-specific antigen (PSA) promoter confer androgen-independent expression of PSA in prostate cancer cells, J BIOL CHEM, 275(52), 2000, pp. 40846-40855
Authors:
Mononen, N
Syrjakoski, K
Matikainen, M
Tammela, TLJ
Schleutker, J
Kallioniemi, OP
Trapman, J
Koivisto, PA
Citation: N. Mononen et al., Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene, CANCER RES, 60(22), 2000, pp. 6479-6481
Authors:
Koivisto, PA
Schleutker, J
Helin, H
Ehren-van Eekelen, C
Kallioniemi, OP
Trapman, J
Citation: Pa. Koivisto et al., Androgen receptor gene alterations and chromosomal gains and losses in prostate carcinomas appearing during finasteride treatment for benign prostatic hyperplasia, CLIN CANC R, 5(11), 1999, pp. 3578-3582
Authors:
Van Alewijk, DC
Van Der Weiden, MM
Eussen, BJ
Van Den Andel-Thijssen, LD
Ehren-Van Eekelen, CC
Konig, JJ
Van Steenbrugge, GJ
Dinjens, WN
Trapman, J
Citation: Dc. Van Alewijk et al., Identification of a homozygous deletion at 8p12-21 in a human prostate cancer xenograft, GENE CHROM, 24(2), 1999, pp. 119-126
Authors:
Dubbink, HJ
Cleutjens, KBJM
van der Korput, HAGM
Trapman, J
Romijn, JC
Citation: Hj. Dubbink et al., An Sp1 binding site is essential for basal activity of the human prostate-specific transglutaminase gene (TGM4) promoter, GENE, 240(2), 1999, pp. 261-267
Authors:
Verkaik, NS
Trapman, J
Romijn, JC
Van der Kwast, TH
Van Steenbrugge, GJ
Citation: Ns. Verkaik et al., Down-regulation of CD44 expression in human prostatic carcinoma cell linesis correlated with DNA hypermethylation, INT J CANC, 80(3), 1999, pp. 439-443